DUBLIN, Ireland--(BUSINESS WIRE)--Jan. 16, 2014-- Covidien plc (NYSE: COV) today announced that its Board of Directors has declared a quarterly cash dividend of $0.32 per ordinary share. The dividend is payable on February 20, 2014, to shareholders of record on January 28, 2014.

About Covidien

Covidien is a leading global healthcare products company that creates innovative medical solutions for better patient outcomes and delivers value through clinical leadership and excellence. Covidien develops, manufactures and sells a diverse range of industry-leading medical device and supply products. With 2013 revenue of $10.2 billion, Covidien has more than 38,000 employees worldwide in more than 70 countries, and its products are sold in over 150 countries. Please visit www.covidien.com to learn more about our business.

Source: Covidien plc

Covidien plc
Peter Lucht, 508-452-4168
Vice President, External Communications
peter.lucht@covidien.com
or
Lisa Clemence, 508-452-4375
Director, Corporate Communications
lisa.clemence@covidien.com
or
Coleman Lannum, CFA, 508-452-4343
Vice President, Investor Relations
cole.lannum@covidien.com
or
Todd Carpenter, 508-452-4363
Senior Director, Investor Relations
todd.carpenter@covidien.com